Literature DB >> 4758074

Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat, and mouse.

M A Schwartz, E Postma, S J Kolis, A S Leon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4758074     DOI: 10.1002/jps.2600621108

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Biopharmaceutical and clinical pharmacokinetic profile of bromazepam.

Authors:  S A Kaplan; M L Jack; R E Weinfeld; W Glover; L Weissman; S Cotler
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

Review 2.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers.

Authors:  Manami Oda; Tsutomu Kotegawa; Kimiko Tsutsumi; Yasukiyo Ohtani; Keiji Kuwatani; Shigeyuki Nakano
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

4.  Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.

Authors: 
Journal:  J R Coll Gen Pract       Date:  1984-09

5.  Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.

Authors:  H Boxenbaum
Journal:  J Pharmacokinet Biopharm       Date:  1980-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.